Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy.

Molecular vision - 1 Jan 2017

Paine Suman K, Mondal Lakshmi K, Borah Prasanta K, Bhattacharya Chandra K, Mahanta Jagadish

Abstract excerpt

PURPOSE: Alteration of pro- and antiangiogenic homeostasis of vascular endothelial growth factor (VEGF) isoforms in patients with hyperglycemia seems crucial but substantially unexplored at least quantitatively for diabetic retinopathy (DR). Therefore, in the present study we aimed to estimate the difference between the pro- (VEGF165a) and antiangiogenic (VEGF165b) VEGF isoforms and its soluble receptors for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Demography
Share to Diabetic Retinopathy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Receptors, Vascular Endothelial Growth Factor

Share to Severity of Illness Index

Share to Vascular Endothelial Growth Factor A

Source

Open in PubMed Open full text

Identifiers

PMID: 28680264
PMCID: PMC5482372

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy.PMID 28680264Read ↗

[The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].Semantic proximity Read ↗

Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.Semantic proximity Read ↗

Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy.Semantic proximity Read ↗

Association of vascular endothelial growth factor A gene (VEGFA) polymorphisms, rs699947 and rs1570360, with diabetic retinopathy and altered VEGF secretion in Pakistani patients with Type 2 diabetes mellitus: A case-control studySemantic proximity Read ↗

Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.Semantic proximity Read ↗

A Study of VEGF Gene Polymorphism in Egyptian Patients with Diabetic Retinopathy.Semantic proximity Read ↗

Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.Semantic proximity Read ↗

What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?Semantic proximity Read ↗

Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes.Semantic proximity Read ↗

VEGF polymorphisms are associated with severity of diabetic retinopathy.Semantic proximity Read ↗

Association between VEGF polymorphisms and diabetic retinopathy in Thai patients with type 2 diabetes.Semantic proximity Read ↗

TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic RetinopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.